Do you still think Blueprint Medicines Corp (NASDAQ:BPMC) is worth a look?
In yesterday’s Wall Street session, Blueprint Medicines Corp (NASDAQ:BPMC) shares traded at $67.01, up 1.07% from the previous session. As of this writing, 19 analysts cover Blueprint Medicines Corp (NASDAQ:BPMC). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $114.00 and a […]
A Stock With Stellar Fundamentals? Blueprint Medicines Corporation (NASDAQ:BPMC): Is It Right For You?
In yesterday’s Wall Street session, Blueprint Medicines Corporation (NASDAQ:BPMC) shares traded at $54.30, down -15.34% from the previous session. As of this writing, 19 analysts cover Blueprint Medicines Corporation (NASDAQ:BPMC). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $114.00 and a […]
